Cargando…
MEDB-35. Relationship between genetic profile, histology, clinical features and long-term outcome in young children medulloblastoma (YCMB) treated with upfront high dose chemotherapy (HDCT) in Italy
AIMS: We report a cohort of YCMB cases homogeneously treated with HDCT in two Italian institutions, and the prognostic impact of histology and genetics retrospectively evaluated. METHODS: All YCMB (aged≤3 years) treated with upfront HDCT in the period 1998-2019 were included, reclassified according...
Autores principales: | Garrè, Maria Luisa, Massimino, Maura, Buttarelli, Francesca Romana, Gandola, Lorenza, Barra, Salvina, Giangaspero, Felice, Goschzik, Tobias, Biassoni, Veronica, Pastorino, Lorenza, Pistorio, Angela, Pietsch, Torsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164752/ http://dx.doi.org/10.1093/neuonc/noac079.409 |
Ejemplares similares
-
MEDB-68. Analysis of telomeres length and Alternative Lengthening of Telomeres (ALT) in molecular subgroups of infant medulloblastoma
por: Buttarelli, Francesca Romana, et al.
Publicado: (2022) -
MEDB-40. RUNNING FOR INCLUSION IN SIOPE PNET5 MB
por: Massimino, Maura, et al.
Publicado: (2022) -
MEDB-75. Treatment-induced pulmonary toxicity in patients with medulloblastoma: a retrospective analysis on 2 Italian institutions’ cohorts
por: Biassoni, Veronica, et al.
Publicado: (2022) -
MEDB-61. Genetic alterations ofTP53 andOTX2 indicate increased risk of relapse in WNT medulloblastomas
por: Goschzik, Tobias, et al.
Publicado: (2022) -
MEDB-09. Unraveling the role of unfolded protein response in medulloblastoma cancer stem cells
por: Spinello, Zaira, et al.
Publicado: (2022)